Design, Synthesis, and Biological Study of Novel Farnesoid X Receptor Agonist for the Treatment of Cholestatic Liver Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, Synthesis, and Biological Study of Novel Farnesoid X Receptor Agonist for the Treatment of Cholestatic Liver Disease

Published:2022-09-13 Issue:35 Volume:7 Page:
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Wang Han¹,Sun Yating¹,Li Hewei²,Yang Shengli³,Yi Wen¹^ORCID

Affiliation:

1. Huazhong University of Science and Technology Hospital WuHan 430074 China

2. Liyuan Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology WuHan 430074 China

3. Xiehe Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology WuHan 430074 China

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202201573

Reference27 articles.

2. The metabolomic window into hepatobiliary disease

3. Molecular mechanisms of cholestasis: causes and consequences of impaired bile formation

4. The ascending pathophysiology of cholestatic liver disease

5. Primary biliary cholangitis: pathogenesis and therapeutic opportunities

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP